Front Row Advisors’s Amedisys AMED Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-27
| Closed | -$2.48K | – | 514 |
|
2024
Q2 | $2.48K | Hold |
27
| – | – | ﹤0.01% | 831 |
|
2024
Q1 | $2.49K | Buy |
+27
| New | +$2.49K | ﹤0.01% | 822 |
|
2023
Q4 | – | Sell |
-27
| Closed | -$2.52K | – | 487 |
|
2023
Q3 | $2.52K | Hold |
27
| – | – | ﹤0.01% | 786 |
|
2023
Q2 | $2K | Hold |
27
| – | – | ﹤0.01% | 791 |
|
2023
Q1 | $2K | Hold |
27
| – | – | ﹤0.01% | 806 |
|
2022
Q4 | $2K | Hold |
27
| – | – | ﹤0.01% | 770 |
|
2022
Q3 | $3K | Hold |
27
| – | – | ﹤0.01% | 736 |
|
2022
Q2 | $3K | Hold |
27
| – | – | ﹤0.01% | 744 |
|
2022
Q1 | $5K | Hold |
27
| – | – | ﹤0.01% | 704 |
|
2021
Q4 | $4K | Hold |
27
| – | – | ﹤0.01% | 775 |
|
2021
Q3 | $4K | Hold |
27
| – | – | ﹤0.01% | 763 |
|
2021
Q2 | $5K | Hold |
27
| – | – | ﹤0.01% | 727 |
|
2021
Q1 | $7K | Hold |
27
| – | – | ﹤0.01% | 620 |
|
2020
Q4 | $8K | Hold |
27
| – | – | ﹤0.01% | 559 |
|
2020
Q3 | $6K | Hold |
27
| – | – | ﹤0.01% | 626 |
|
2020
Q2 | $5K | Hold |
27
| – | – | ﹤0.01% | 614 |
|
2020
Q1 | $5K | Sell |
27
-10
| -27% | -$1.85K | ﹤0.01% | 604 |
|
2019
Q4 | $6K | Hold |
37
| – | – | ﹤0.01% | 565 |
|
2019
Q3 | $5K | Hold |
37
| – | – | ﹤0.01% | 576 |
|
2019
Q2 | $4K | Hold |
37
| – | – | ﹤0.01% | 624 |
|
2019
Q1 | $5K | Hold |
37
| – | – | ﹤0.01% | 567 |
|
2018
Q4 | $4K | Hold |
37
| – | – | ﹤0.01% | 575 |
|
2018
Q3 | $4 | Hold |
37
| – | – | ﹤0.01% | 590 |
|
2018
Q2 | $3 | Hold |
37
| – | – | ﹤0.01% | 725 |
|
2018
Q1 | $2K | Hold |
37
| – | – | ﹤0.01% | 763 |
|
2017
Q4 | $2K | Buy |
+37
| New | +$2K | ﹤0.01% | 661 |
|